Olga D Carlson Selected Research

Olga D Carlson Research Topics

Disease

8	Insulin Resistance 02/2019 - 10/2007
8	Type 2 Diabetes Mellitus (MODY) 02/2019 - 06/2009
5	Obesity 01/2018 - 12/2005
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2019 - 02/2010
3	Hyperglycemia 06/2009 - 08/2007
2	Weight Gain 01/2018 - 10/2013
2	Inflammation (Inflammations) 01/2018 - 03/2014
2	Weight Loss (Weight Reduction) 01/2016 - 10/2013
2	Prediabetic State (Prediabetes) 07/2014 - 10/2013
2	Body Weight (Weight, Body) 05/2010 - 06/2008
1	Hypoglycemia (Reactive Hypoglycemia) 01/2022
1	Neoplasms (Cancer) 02/2019
1	Fatigue 01/2019
1	Frailty 01/2019
1	Sarcopenia 01/2019
1	Glucosephosphate Dehydrogenase Deficiency 09/2017
1	Alzheimer Disease (Alzheimer's Disease) 07/2015
1	Frontotemporal Dementia (Semantic Dementia) 07/2015
1	Hyperinsulinism (Hyperinsulinemia) 11/2014
1	Dementia (Dementias) 03/2014
1	Cognitive Dysfunction 03/2014
1	Cerebral Cortical Thinning 03/2014
1	Chronic Disease (Chronic Diseases) 03/2014
1	Overweight 10/2013
1	Metabolic Diseases (Metabolic Disease) 10/2013
1	Breast Neoplasms (Breast Cancer) 10/2013
1	Disease Progression 09/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2011
1	Prostatic Neoplasms (Prostate Cancer) 01/2011
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2011
1	Marfan Syndrome (Marfan's Syndrome) 08/2009
1	Bites and Stings (Sting) 06/2009
1	Huntington Disease (Huntington's Disease) 02/2009
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2009
1	Diabetes Mellitus 10/2007
1	Glucose Intolerance 10/2007

Drug/Important Bio-Agent (IBA)

15	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 08/2007
7	Insulin (Novolin)FDA Link 01/2022 - 06/2008
4	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2014 - 09/2007
3	Peptides (Polypeptides)IBA 01/2019 - 06/2009
3	Hormones (Hormone)IBA 07/2014 - 05/2010
3	AdiponectinIBA 01/2012 - 02/2010
2	IncretinsIBA 01/2022 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 03/2014
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2015
2	SugarsIBA 01/2018 - 10/2013
2	CannabinoidsIBA 01/2018 - 01/2016
2	Saline SolutionIBA 07/2014 - 06/2009
2	Exenatide (Byetta)FDA Link 09/2012 - 02/2009
2	LeptinIBA 06/2011 - 06/2008
1	Insulin-Like Growth Factor I (IGF-1)IBA 02/2019
1	Insulin-Like PeptidesIBA 02/2019
1	Insulin-Like Growth Factor Binding Protein 2IBA 02/2019
1	LipidsIBA 01/2018
1	Sweetening Agents (Sweeteners)IBA 01/2018
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2018
1	Insulin ReceptorIBA 01/2018
1	Amino Acids FDA Link 01/2018
1	Hemoglobins (Hemoglobin)IBA 09/2017
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2017
1	EndocannabinoidsIBA 01/2017
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 07/2015
1	ElementsIBA 07/2015
1	Low Density Lipoprotein Receptor-Related Protein-6IBA 07/2015
1	Glucagon (Glukagon)FDA Link 07/2014
1	Metformin (Glucophage)FDA LinkGeneric 07/2014
1	Biomarkers (Surrogate Marker)IBA 03/2014
1	CarbohydratesIBA 10/2013
1	Sirtuin 1IBA 10/2013
1	ResveratrolIBA 10/2013
1	fibroblast growth factor 21IBA 04/2012
1	OsteocalcinIBA 06/2011
1	AndrogensIBA 01/2011
1	IsoflavonesIBA 01/2011
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 04/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 08/2009
1	Fibrillin-1IBA 08/2009
1	Glucagon-Like Peptides (Enteroglucagon)IBA 06/2009
1	gastric inhibitory polypeptide receptorIBA 06/2009
1	Acetaminophen (Paracetamol)FDA LinkGeneric 06/2009
1	Blood Glucose (Blood Sugar)IBA 02/2009
1	Huntingtin ProteinIBA 02/2009
1	Glucagon-Like Peptide-1 ReceptorIBA 02/2009
1	polyglutamineIBA 02/2009
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2009
1	Nonesterified Fatty Acids (NEFA)IBA 10/2007
1	Peptide YYIBA 12/2005

Therapy/Procedure

2	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2022 - 11/2014
2	Glycemic Control 09/2017 - 02/2009
2	Therapeutics 01/2016 - 01/2011
1	Gastrectomy 01/2022
1	Bariatric Surgery 11/2014